Page 31 - Peter Marks News Today

The Centers for Disease Control and Prevention says 100,000 Americans are living with sickle cell disease.

The FDA approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease in patients 12 years and older. One of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology.

The FDA has approved two new gene therapies for sickle cell disease, a 'functional cure' for many patients

The FDA has approved two new gene therapies for sickle cell disease, a 'functional cure' for many patients

The Centers for Disease Control and Prevention says 100,000 Americans are living with sickle cell disease.

The FDA has approved two new gene therapies for sickle cell disease, a 'functional cure' for many patients

The FDA has approved Casgevy and Lyfgenia, the first cell-based gene therapies for the treatment of sickle cell disease in patients 12 years of age and older.

This FDA approval represents the first cell-based gene therapies for the treatment of sickle cell disease in patients 12 years of age and older.

Pryzm Plymouth will close for good after a final New Year’s Eve party as the cost-of-living crisis squeezes student budgets.

Edith P. “Heidi” Simmons was recently honored at a reception commending her for her many years of service as a public-school teacher and as an elected member of the Stonington Board of Education ...